Zdrowie i gospodarka · 18/02/2014

FDA Clears Six Drug Products, Including GANITE, for Sale

The Food and Drug Administration (FDA) has determined that six drug products, including GANITE (Gallium Nitrate) Injectable, were not withdrawn from sale due to safety or effectiveness concerns. This decision means the FDA will not initiate withdrawal procedures and will continue to approve Abbreviated New Drug Applications (ANDAs) for these products as long as they meet regulatory requirements.